Circumvent PCV M G2 – PCV2 & Mycoplasma Defense

As most people know, kids and swine are exposed to major threats in life with the causes of those deaths being diseases. Merck Circumvent PCV M G2 protects animals from being exposed to Porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae. In addition, the new vaccine causes decreases in respiratory disease while strengthening overall herd health and preventing losses in production. With its long history of disease prevention, Circumvent PCV M G2 is indispensable for swine producers fighting such causes to minimize losses while maximizing growth performance.

Benefits:

• Comprehensive Protection – Protects against both PCV2 and Mycoplasma hyopneumoniae with a single dose.
• Boosted Immune Response – Adjuvanted preparation enhances immunity for long-term protection.
• Flexible Dosing – Available for use in pigs as early as 3 weeks of age, providing protection early.
• Lung Lesions Reduced – Helps lower lung lesions and improve respiratory health.
• Proven Efficacy – Merck's credible experience in animal health, is backed by a voluminous set of research.

What is the age limit for pigs to be given the Circumvent PCVMG2 vaccination?

The vaccination may be given within 3 weeks of age for maximum protection from PCV2 and Mycoplasma hyopneumoniae.

How is the Circumvent PCVMG2 vaccine propagated?

The vaccine is given intramuscularly (IM) strictly according to the manufacturer's dosage recommendations.